Nicotine Patch Safety Study

NCT01655082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Smokers

Interventions

DRUG: V0116 transdermal patch
DRUG: Nicotine transdermal patch

Sponsor

Pierre Fabre Medicament